|
|
|
96TH GENERAL ASSEMBLY
State of Illinois
2009 and 2010
HB2634
Introduced 2/20/2009, by Rep. Julie Hamos SYNOPSIS AS INTRODUCED:
|
|
|
Creates the Pediatric Palliative Care Act. Provides that the Department of Healthcare and Family Services shall develop a pediatric palliative care pilot program under which a qualifying child may receive community-based pediatric palliative care from a trained interdisciplinary team while continuing to pursue aggressive curative treatments for a potentially life-limiting medical condition under the benefits available under the Medicaid program. Provides that the Department shall apply for a federal waiver to conduct the program. Provides that a "qualifying child" for the pilot program is a child under the age of 18 years who is enrolled in the Medicaid program and suffers from a potentially life-limiting medical condition. Sets forth certain counties to be included in the pilot program. Requires a report to the General Assembly at the end of the 3-year pilot period. Effective immediately.
|
| |
|
|
| FISCAL NOTE ACT MAY APPLY | |
|
|
A BILL FOR
|
|
|
|
|
HB2634 |
|
LRB096 10826 DRJ 21049 b |
|
|
1 |
| AN ACT concerning public aid.
|
2 |
| Be it enacted by the People of the State of Illinois,
|
3 |
| represented in the General Assembly:
|
4 |
| Section 1. Short title. This Act may be cited as the |
5 |
| Pediatric Palliative Care Act.
|
6 |
| Section 5. Legislative findings. The General Assembly |
7 |
| finds as follows: |
8 |
| (1) Each year, approximately 1,185 Illinois children |
9 |
| are diagnosed with a potentially life-limiting illness. |
10 |
| (2) There are many barriers to the provision of |
11 |
| pediatric palliative services, the most significant of |
12 |
| which include the following: (i) challenges in predicting |
13 |
| life expectancy; (ii) the reluctance of families and |
14 |
| professionals to acknowledge a child's incurable |
15 |
| condition; and (iii) the lack of an appropriate, |
16 |
| pediatric-focused reimbursement structure leading to |
17 |
| insufficient community-based resources. |
18 |
| (3) It is tremendously difficult for physicians to |
19 |
| prognosticate pediatric life expectancy due to the |
20 |
| resiliency of children. In addition, parents are rarely |
21 |
| prepared to cease curative efforts in order to receive |
22 |
| hospice or palliative care. Community-based pediatric |
23 |
| palliative services, however, keep children out of the |
|
|
|
HB2634 |
- 2 - |
LRB096 10826 DRJ 21049 b |
|
|
1 |
| hospital by managing many symptoms in the home setting, |
2 |
| thereby improving childhood quality of life while |
3 |
| maintaining budget neutrality.
|
4 |
| Section 10. Definition. In this Act, "Department" means the |
5 |
| Department of Healthcare and Family Services.
|
6 |
| Section 15. Pediatric palliative care pilot program. The |
7 |
| Department shall develop a pediatric palliative care pilot |
8 |
| program under which a qualifying child as defined in Section 25 |
9 |
| may receive community-based pediatric palliative care from a |
10 |
| trained interdisciplinary team while continuing to pursue |
11 |
| aggressive curative treatments for a potentially life-limiting |
12 |
| illness under the benefits available under Article V of the |
13 |
| Illinois Public Aid Code.
|
14 |
| Section 20. Federal waiver. The Department shall submit the |
15 |
| necessary application to the federal Centers for Medicare and |
16 |
| Medicaid Services for a waiver to implement the pilot program |
17 |
| described in this Act. The waiver request shall be included in |
18 |
| any appropriate waiver application renewal submitted within 12 |
19 |
| months after the effective date of this Act, or shall be |
20 |
| submitted as an independent 1915(c) Home and Community Based |
21 |
| Medicaid Waiver within that same time period. After federal |
22 |
| approval is secured, the Department shall implement the pilot |
23 |
| program under the waiver within 12 months after the date of |
|
|
|
HB2634 |
- 3 - |
LRB096 10826 DRJ 21049 b |
|
|
1 |
| approval. The pilot program shall be implemented only to the |
2 |
| extent that federal financial participation is available.
|
3 |
| Section 25. Qualifying child. |
4 |
| (a) For the purposes of this Act, a qualifying child is a |
5 |
| person under 18 years of age who is enrolled in the medical |
6 |
| assistance program under Article V of the Illinois Public Aid |
7 |
| Code and suffers from a potentially life-limiting medical |
8 |
| condition, as defined in subsection (b). A child who is |
9 |
| enrolled in the pilot program prior to the age 18 may continue |
10 |
| to receive services under the pilot program until the day |
11 |
| before his or her twenty-first birthday.
|
12 |
| (b) The Department, in consultation with interested |
13 |
| stakeholders, shall determine the potentially life-limiting |
14 |
| medical conditions that render a pediatric medical assistance |
15 |
| recipient eligible for the pilot program under this Act. Such |
16 |
| medical conditions shall include, but need not be limited to, |
17 |
| the following: |
18 |
| (1) Cancer (i) for which there is no known effective |
19 |
| treatment, (ii) that does not respond to conventional |
20 |
| protocol, (iii) that has progressed to an advanced stage, |
21 |
| or (iv) where toxicities or other complications prohibit |
22 |
| the administration of curative therapies. |
23 |
| (2) End-stage lung disease, including but not limited |
24 |
| to cystic fibrosis, that results in dependence on |
25 |
| technology, such as mechanical ventilation. |
|
|
|
HB2634 |
- 4 - |
LRB096 10826 DRJ 21049 b |
|
|
1 |
| (3) Severe neurological conditions, including, but not |
2 |
| limited to, hypoxic ischemic encephalopathy, acute brain |
3 |
| injury, brain infections and inflammatory diseases, or |
4 |
| irreversible severe alteration of mental status, with one |
5 |
| of the following co-morbidities: (i) intractable seizures |
6 |
| or (ii) brainstem failure to control breathing or other |
7 |
| automatic physiologic functions. |
8 |
| (4) Degenerative neuromuscular conditions, including, |
9 |
| but not limited to, spinal muscular atrophy, Type I or II, |
10 |
| or Duchenne Muscular Dystrophy, requiring technological |
11 |
| support. |
12 |
| (5) Genetic syndromes, such as Trisomy 13 or 18, where |
13 |
| (i) it is more likely than not that the child will not live |
14 |
| past 2 years of age or (ii) the child is severely |
15 |
| compromised with no expectation of long-term survival. |
16 |
| (6) Congenital or acquired end-stage heart disease, |
17 |
| including but not limited to the following: (i) single |
18 |
| ventricle disorders, including hypoplastic left heart |
19 |
| syndrome; (ii) total anomalous pulmonary venous return, |
20 |
| not suitable for curative surgical treatment; and (iii) |
21 |
| heart muscle disorders (cardiomyopathies) without adequate |
22 |
| medical or surgical treatments. |
23 |
| (7) End-stage liver disease where (i) transplant is not |
24 |
| a viable option or (ii) transplant rejection or failure has |
25 |
| occurred. |
26 |
| (8) End-stage kidney failure where (i) transplant is |
|
|
|
HB2634 |
- 5 - |
LRB096 10826 DRJ 21049 b |
|
|
1 |
| not a viable option or (ii) transplant rejection or failure |
2 |
| has occurred. |
3 |
| (9) Metabolic or biochemical disorders, including, but |
4 |
| not limited to, mitochondrial disease, leukodystrophies, |
5 |
| Tay-Sachs disease, or Lesch-Nyhan syndrome where (i) no |
6 |
| suitable therapies exist or (ii) available treatments, |
7 |
| including stem cell ("bone marrow") transplant, have |
8 |
| failed. |
9 |
| (10) Congenital or acquired diseases of the |
10 |
| gastrointestinal system, such as "short bowel syndrome", |
11 |
| where (i) transplant is not a viable option or (ii) |
12 |
| transplant rejection or failure has occurred. |
13 |
| (11) Congenital skin disorders, including but not |
14 |
| limited to epidermolysis bullosa, where no suitable |
15 |
| treatment exists.
|
16 |
| The definition of a life-limiting medical condition shall |
17 |
| not include a definitive time period due to the difficulty and |
18 |
| challenges of prognosticating life expectancy in children.
|
19 |
| Section 30. Authorized providers. Providers authorized to |
20 |
| deliver services under the pilot program shall include licensed |
21 |
| hospice programs or home health agencies licensed to provide |
22 |
| hospice care and are subject to further criteria developed by |
23 |
| the Department for provider participation. At a minimum, a |
24 |
| participating provider must employ a pediatric-trained |
25 |
| interdisciplinary team that includes a pediatric medical |
|
|
|
HB2634 |
- 6 - |
LRB096 10826 DRJ 21049 b |
|
|
1 |
| director, a nurse, and a licensed social worker. All members of |
2 |
| the pediatric interdisciplinary team must submit to the |
3 |
| Department proof of pediatric End-of-Life Nursing Education |
4 |
| Curriculum (Pediatric ELNEC) Training or an equivalent.
|
5 |
| Section 35. Included counties. Services under the pilot |
6 |
| program shall be made available in Illinois counties with |
7 |
| licensed hospice programs that report and demonstrate, as |
8 |
| described in Section 30, the ability to deliver the pediatric |
9 |
| palliative services described in this Act. Without limiting the |
10 |
| ability of licensed hospice programs in other counties to apply |
11 |
| for participation in the pilot program, the following counties |
12 |
| shall be included in the pilot program: Boone, Cass, Christian, |
13 |
| Clark, Coles, Cook, Crawford, Cumberland, DeWitt, Douglas, |
14 |
| DuPage, Edgar, Effingham, Fayette, Grundy, Jasper, Kane, |
15 |
| Kankakee, Kendall, Logan, Macon, Mason, McHenry, Menard, |
16 |
| Morgan, Moultrie, Ogle, Piatt, Sangamon, Shelby, Will, and |
17 |
| Winnebago.
|
18 |
| Section 40. Interdisciplinary team; services. The |
19 |
| reimbursable services offered under the pilot program shall be |
20 |
| provided by an interdisciplinary team, operating under the |
21 |
| direction of a pediatric medical director, and shall include, |
22 |
| but not be limited to, the following: |
23 |
| (1) Pediatric nursing for pain and symptom management. |
24 |
| (2) Expressive therapies (music and art therapies) for |
|
|
|
HB2634 |
- 7 - |
LRB096 10826 DRJ 21049 b |
|
|
1 |
| age-appropriate counseling. |
2 |
| (3) Client and family counseling (provided by a |
3 |
| licensed social worker or non-denominational chaplain or |
4 |
| spiritual counselor). |
5 |
| (4) Respite care. |
6 |
| (5) Bereavement services. |
7 |
| (6) Case management.
|
8 |
| Section 45. Administration. |
9 |
| (a) The Department shall oversee the administration of the |
10 |
| pilot program. The Department, in consultation with interested |
11 |
| stakeholders, shall determine the appropriate process for |
12 |
| review of referrals and enrollment of qualifying participants. |
13 |
| (b) The Department shall appoint an individual to serve as |
14 |
| case manager or an alternative position to assess level-of-care |
15 |
| and target-population criteria for the pilot program. The |
16 |
| Department shall ensure that the individual receives pediatric |
17 |
| End-of-Life Nursing Education Curriculum (Pediatric ELNEC) |
18 |
| Training or an equivalent to become familiarized with the |
19 |
| unique needs and difficulties facing this population. The |
20 |
| process for review of referrals and enrollment of qualifying |
21 |
| participants shall not include unnecessary delays and shall |
22 |
| reflect the fact that treatment of pain and other distressing |
23 |
| symptoms represents an urgent need for children with |
24 |
| life-limiting medical conditions. The process shall also |
25 |
| acknowledge that children with life-limiting medical |
|
|
|
HB2634 |
- 8 - |
LRB096 10826 DRJ 21049 b |
|
|
1 |
| conditions and their families require holistic and seamless |
2 |
| care.
|
3 |
| Section 50. Period of pilot program. |
4 |
| (a) The program implemented under this Act shall be |
5 |
| considered a pilot program for 3 years following the date of |
6 |
| program implementation or until the waiver that includes the |
7 |
| services provided under the program undergoes the federally |
8 |
| mandated renewal process. |
9 |
| (b) During the period of time that the program is |
10 |
| considered a pilot program, pediatric palliative care shall be |
11 |
| included in the issues reviewed by the Hospice and Palliative |
12 |
| Care Advisory Board. The Board shall make recommendations |
13 |
| regarding changes or improvements to the program, including but |
14 |
| not limited to advice on potential expansion of the potentially |
15 |
| life-limiting medical conditions as defined in subsection (b) |
16 |
| of Section 25. |
17 |
| (c) At the end of the 3-year pilot program, the Department |
18 |
| shall submit a report to the General Assembly concerning the |
19 |
| program's outcomes effectiveness and shall also make |
20 |
| recommendations for program improvement, including, but not |
21 |
| limited to, the appropriateness of the potentially |
22 |
| life-limiting medical conditions as defined in subsection (b) |
23 |
| of Section 25.
|
24 |
| Section 55. Effect on medical assistance program. |
|
|
|
HB2634 |
- 9 - |
LRB096 10826 DRJ 21049 b |
|
|
1 |
| (a) Nothing in this Act shall be construed so as to result |
2 |
| in the elimination or reduction of any benefits or services |
3 |
| covered under the medical assistance program under Article V of |
4 |
| the Illinois Public Aid Code. |
5 |
| (b) This Act does not affect an individual's eligibility to |
6 |
| receive, concurrently with the benefits provided for in this |
7 |
| Act, any services, including home health services, for which |
8 |
| the individual would have been eligible in the absence of this |
9 |
| Act.
|
10 |
| Section 90. The Hospice Program Licensing Act is amended by |
11 |
| changing Section 15 as follows:
|
12 |
| (210 ILCS 60/15) |
13 |
| Sec. 15. Hospice and Palliative Care Advisory Board. |
14 |
| (a) The Director shall appoint a Hospice and Palliative |
15 |
| Care Advisory Board ("the Board") to consult with the |
16 |
| Department as provided in this Section. The membership of the |
17 |
| Board shall be as follows: |
18 |
| (1) The Director, ex officio, who shall be a nonvoting |
19 |
| member and shall serve as chairman of the Board. |
20 |
| (2) One representative of each of the following State |
21 |
| agencies, each of whom shall be a nonvoting member: the |
22 |
| Department of
Healthcare and Family Services, the |
23 |
| Department of Human Services, and the Department on Aging. |
24 |
| (3) One member who is a physician licensed to
practice |
|
|
|
HB2634 |
- 10 - |
LRB096 10826 DRJ 21049 b |
|
|
1 |
| medicine in all its branches, selected from the |
2 |
| recommendations of a statewide professional society |
3 |
| representing physicians licensed to practice medicine in |
4 |
| all its branches in all specialties. |
5 |
| (4) One member who is a registered nurse,
selected from |
6 |
| the recommendations of professional nursing associations. |
7 |
| (5) Four members selected from the
recommendations of |
8 |
| organizations whose primary membership consists of hospice |
9 |
| programs. |
10 |
| (6) Two members who represent the general
public and |
11 |
| who have no responsibility for management or formation of |
12 |
| policy of a hospice program and no financial interest in a |
13 |
| hospice program. |
14 |
| (7) One member selected from the
recommendations of |
15 |
| consumer organizations that engage in advocacy or legal |
16 |
| representation on behalf of hospice patients and their |
17 |
| immediate families. |
18 |
| (b) Of the initial appointees, 4 shall serve for terms of 2 |
19 |
| years, 4 shall serve for terms of 3 years, and 5 shall serve |
20 |
| for terms of 4 years, as determined by lot at the first meeting |
21 |
| of the Board. Each successor member shall be appointed for a |
22 |
| term of 4 years. A member appointed to fill a vacancy before |
23 |
| the expiration of the term for which his or her predecessor was |
24 |
| appointed shall be appointed to serve for the remainder of that |
25 |
| term. |
26 |
| (c) The Board shall meet as frequently as the chairman |
|
|
|
HB2634 |
- 11 - |
LRB096 10826 DRJ 21049 b |
|
|
1 |
| deems necessary, but not less than 4 times each year. Upon the |
2 |
| request of 4 or more Board members, the chairman shall call a |
3 |
| meeting of the Board. A Board member may designate a |
4 |
| replacement to serve at a Board meeting in place of the member |
5 |
| by submitting a letter stating that designation to the chairman |
6 |
| before or at the Board meeting. The replacement member must |
7 |
| represent the same general interests as the member being |
8 |
| replaced, as described in paragraphs (1) through (7) of |
9 |
| subsection (a). |
10 |
| (d) Board members are entitled to reimbursement for their |
11 |
| actual expenses incurred in performing their duties. |
12 |
| (e) The Board shall advise the Department on all aspects of |
13 |
| the Department's responsibilities under this Act, including |
14 |
| the format and content of any rules adopted by the Department |
15 |
| on or after the effective date of this amendatory Act of the |
16 |
| 95th General Assembly. Any such rule or amendment to a rule |
17 |
| proposed on or after the effective date of this amendatory Act |
18 |
| of the 95th General Assembly, except an emergency rule adopted |
19 |
| pursuant to Section 5-45 of the Illinois Administrative |
20 |
| Procedure Act, that is adopted without obtaining the advice of |
21 |
| the Board is null and void. If the Department fails to follow |
22 |
| the advice of the Board with respect to a proposed rule or |
23 |
| amendment to a rule, the Department shall, before adopting the |
24 |
| rule or amendment to a rule, transmit a written explanation of |
25 |
| the reason for its action to the Board. During its review of |
26 |
| rules, the Board shall analyze the economic and regulatory |
|
|
|
HB2634 |
- 12 - |
LRB096 10826 DRJ 21049 b |
|
|
1 |
| impact of those rules. If the Board, having been asked for its |
2 |
| advice with respect to a proposed rule or amendment to a rule, |
3 |
| fails to advise the Department within 90 days, the proposed |
4 |
| rule or amendment shall be considered to have been acted upon |
5 |
| by the Board.
|
6 |
| (f) The Board shall also review pediatric palliative care |
7 |
| issues as provided in the Pediatric Palliative Care Act. |
8 |
| (Source: P.A. 95-133, eff. 1-1-08.)
|
9 |
| Section 99. Effective date. This Act takes effect upon |
10 |
| becoming law.
|